Norgine Ventures

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private, European healthcare company with over 110 years of experience in the pharma space. Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine. To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Yakhya Azashikov

Associate Director

Iakhia Azashikov

Associate Director

Jackie Burton

Finance Director

Grethe Dalsgaard

Associate Director, Scientific Evaluation

Julien Michaux

Managing Director

Lira Popovska

Investment Professional

Moritz Reuter

Investment Associate

Peter Stein

Chairman and CEO

20 past transactions

Impress

Series B in 2022
Impress is the only truly orthodontic DTC player… globally We have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumers

Inovus Ltd

Venture Round in 2022
Inovus Ltd designs and manufactures medical simulation products. The company’s products include take-home laparoscopic simulators and institutional based laparoscopic simulators, as well as simulators for teaching skills in critical care, medicine, and surgery. It serves customers online. The company was founded in 2012 and is based in Saint Helens, United Kingdom.

Magentiq Eye Ltd

Convertible Note in 2021
Magentiq Eye Ltd., a medical device company, which provides products for endoscopic medical procedures. The company offers automatic polyp detection system (APDS); APDS- RT, a software that runs on local device and server and gets the video feed from the endoscopic camera used by the physician in real time; and APDS-OFL, a software that runs in offline mode on pre-recorded colonoscopy videos. It also provides big data management and analysis, computer vision, video analysis, and colonoscopy screening test. The company was founded in 2014 and is based in Haifa, Israel.

ImaginAb

Venture Round in 2021
ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized for clinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics.

Magentiq Eye Ltd

Series A in 2019
Magentiq Eye Ltd., a medical device company, which provides products for endoscopic medical procedures. The company offers automatic polyp detection system (APDS); APDS- RT, a software that runs on local device and server and gets the video feed from the endoscopic camera used by the physician in real time; and APDS-OFL, a software that runs in offline mode on pre-recorded colonoscopy videos. It also provides big data management and analysis, computer vision, video analysis, and colonoscopy screening test. The company was founded in 2014 and is based in Haifa, Israel.

PathoQuest

Series A in 2019
PathoQuest SAS, a biotechnology company, offers a game changing metagenomics approach to improving the breadth of pathogen detection. The company offers products, such as (NGS) based testing approach delivers actionable reports to clinicians, biologists, and biopharmaceutical quality assurance managers and production managers. It provides iDTECTTM Dx Blood test, an approach to the identification of pathogens and iDTECTTM database and software suite that enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection. The company also offers Viral Safety testing service for biopharmaceutical companies. It has strategic alliance with Charles River Laboratories International, Inc. PathoQuest SAS was founded in 2010 and is based in Paris, France.

SpineGuard

Post in 2018
SpineGuard SA is a medical device company headquartered in Vincennes, France, focused on enhancing the safety of spinal surgeries worldwide. Established in 2009, the company designs, develops, and markets innovative products aimed at improving pedicle screw placement during surgical procedures. Its key offerings include the PediGuard Straight probe, PediGuard Curved probe, PediGuard Cannulated probe, and the PediGuard Threaded Device, all designed to facilitate accurate screw placement while minimizing radiation exposure. Additionally, SpineGuard provides the DSG Connect app for real-time signal visualization during pedicle drilling, as well as the DSG smart screw for single-step screw placement. The company's primary goal is to establish PediGuard as the standard of care for safer spinal procedures, ultimately benefiting patients, surgeons, and healthcare providers.

Caresyntax

Venture Round in 2017
Caresyntax Inc. develops a technology platform specializing in surgical analytics to enhance safety and efficiency in hospitals and ambulatory surgical centers. The company offers solutions designed to identify and manage risks, automate workflows, and reduce variability in surgical procedures. Its flagship products include qvident, a performance management software that enables surgical teams to create and share surgical content, and PRIME365, an integration platform that consolidates key surgical data from various sources such as video, audio, patient vitals, and procedural timestamps. Caresyntax's offerings support a range of surgical procedures, from minimally invasive to robotic surgeries, and can be deployed as HIPAA-compliant software through on-premise, cloud-based, or hybrid installations. Established in 1991, Caresyntax is headquartered in Boston, Massachusetts.

EBS Technologies

Venture Round in 2017
EBS Technologies GmbH, founded in 2007 and headquartered in Hennigsdorf, Germany, specializes in developing and commercializing medical devices aimed at treating neurologically induced impairments, particularly visual field loss. The company offers EBS Therapy, a non-invasive optic nerve stimulation treatment that utilizes low-voltage electrical currents to promote neuroregeneration and neuroprotection. This therapy targets conditions resulting from stroke, traumatic brain injury, and glaucoma, among others. With over 15 years of research and clinical experience involving more than 1,200 patients, EBS Technologies has demonstrated through double-blind, randomized studies and clinical observations that its therapy can help partially restore vision in affected individuals. The company received the CE Mark for its stimulation device in 2013 and commenced commercial treatments in 2014. Currently, there are eight EBS Treatment centers operating across Germany, with plans to expand the network further.

Collagen Solutions

Post in 2017
Collagen Solutions is a global provider of medical-grade collagen components and biomaterials, primarily for applications in regenerative medicine, medical devices, and in-vitro diagnostics. The company specializes in developing and manufacturing a range of collagen products, including soluble collagen, powders, fibrillars, gels, and freeze-dried formulations, which are utilized in various medical fields such as orthopaedics, dental care, cardiovascular procedures, and wound management. Additionally, Collagen Solutions offers Bovine Pericardium for bio-prosthetic heart valves and surgical applications. The company supports pharmaceutical and medical device sectors by providing product development and contract manufacturing services, including technology transfer and regulatory assistance. Founded in 2013 and based in London, Collagen Solutions aims to foster long-term commercial relationships by collaborating closely with customers throughout product development and regulatory processes.

PulseCath

Venture Round in 2016
PulseCath is a medical device company, develops, manufactures, and markets circulatory support systems to cardiologists and cardiac surgeons in the Netherlands and internationally. It offers iVAC 3L, a mid-range minimal heart circulatory assist device that generates up to three liters per minute, and offers critical hemodynamic support in the case of left ventricular failure or during high-risk revascularization procedures with potential post cardiotomy weaning complications.

Q3 Medical Devices

Venture Round in 2016
Q3 Medical Devices Limited is a holding company, which through its subsidiaries, engages in the development, manufacturing, and distribution of minimally invasive devices for the treatment of patients with coronary, peripheral vascular, and nonvascular diseases. The company was founded in 2013 and is based in Dublin, Ireland.

SpineVision

Venture Round in 2014
SpineVision is a spinal technology company focused on the development and marketing of implants and instrumentation for spinal treatment. The company offers spinal systems addressing a wide range of spinal pathologies including degenerative disc disease, deformity, cervical disorders, trauma and tumors. These products have been developed in collaboration with leading neurological and orthopedic surgeons which has resulted in over 20 patents. SpineVision was founded in 1999 and is headquartered in Antony in France, with subsidiaries in Belgium, Italy, the United Kingdom, and the United States.

Azanta

Venture Round in 2014
Azanta A/S, a biopharmaceutical company, develops and sells treatments for orphan oncology and women’s health indications. It also offers obstetrics and addiction medicines. The company was formerly known as IPC International A/S and changed its name to Azanta A/S in February 2010. Azanta A/S was founded in 1994 and is based in Copenhagen, Denmark. As of March 24, 2020, Azanta A/S operates as a subsidiary of Norgine B.V.

Agendia

Debt Financing in 2014
Agendia's molecular diagnostic technology provides cancer patients and their physicians with a glimpse into their genome, answers to the most pressing questions and enables personalized treatment plans. Agendia’s breast cancer tests were developed using an unbiased gene selection by analyzing the complete human genome. Agendia’s tests can help physicians assess a patient’s individual risk for metastasis, which patients may benefit from chemo, hormonal or combination therapy, and which patients may not require these treatments and can instead be treated with other, less arduous and less costly methods.

SuperSonic Imagine

Venture Round in 2014
SuperSonic Imagine SA operates as a medical technology company. It designs, develops, and markets Aixplorer, an ultrasound system. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company’s products include Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution. It operates primarily in China, the United States, and France. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.

Stanmore Implants Worldwide

Debt Financing in 2013
Stanmore Implants Worldwide is an innovative orthopaedic business focused on the design and manufacture of both bespoke and modular implants for limb-sparing and complex primary and revision joint replacement. Stanmore Implants Worldwide designs, manufactures and markets a custom implant service alongside a portfolio of orthopaedic implants for limb salvage and complex joint replacement, and is known for creating some of the world's most successful implants. Stanmore Implants Worldwide acquired its robotic bone preparation technology through the acquisition of Acrobot, a medical devices company specializing in computer-assisted orthopaedic surgery in August 2010. Stanmore Implants Worldwide was acquired by Stryker on April 29, 2016. It was founded in 1948 and is headquartered in London, UK.

Internis Pharmaceuticals

Debt Financing in 2013
Internis is an exciting and innovative British start-up business. Founded in 2010, it is a pharmaceutical company engaged in the development and commercialisation of highly effective and innovative new medicines aimed at the treatment and prevention of a range of common bone disorders, such as osteoporosis and vitamin D3 deficiency. Internis supplies a prescription only licensed medicine (FultiumD3) to treat patients with a vitamin D deficiency. Vitamin D is offered to at-risk groups on prescription to prevent the health risks associated with a deficiency or insufficiency. It is estimated that up to a quarter of the population in the UK have low levels of vitamin D in their blood – with deficiency linked to conditions including bone deformities and health complications such as depression, joint pain, migraines, fatigue and a weakened immune system.

SpineGuard

Venture Round in 2012
SpineGuard SA is a medical device company headquartered in Vincennes, France, focused on enhancing the safety of spinal surgeries worldwide. Established in 2009, the company designs, develops, and markets innovative products aimed at improving pedicle screw placement during surgical procedures. Its key offerings include the PediGuard Straight probe, PediGuard Curved probe, PediGuard Cannulated probe, and the PediGuard Threaded Device, all designed to facilitate accurate screw placement while minimizing radiation exposure. Additionally, SpineGuard provides the DSG Connect app for real-time signal visualization during pedicle drilling, as well as the DSG smart screw for single-step screw placement. The company's primary goal is to establish PediGuard as the standard of care for safer spinal procedures, ultimately benefiting patients, surgeons, and healthcare providers.

Medical Vision

Debt Financing in 2012
Medical Vision AB develops, constructs, and produces medical devices used during endoscopic procedures. It offers arthro-tube products, arthroscopy pumps, arthroscopy sets, receptacles, digital camera systems, capture devices, fluid management systems, and double pumps.